Pharmtech&Ingredients – The Main Exhibition of Prospects
Pharmtech & Ingredients is an exhibition project of high importance to the industry that promotes domestic production and cooperation between international innovators and Russian drug-makers. The exhibition opening ceremony was attended by Vadim Kulikov, Deputy General Director of the Agency of Technological Development; Mr. Binaya Srikanta Pradhan, Deputy Chief of Mission at the Embassy of India in the Russian Federation; Viktor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers (ARPM); Oleg Malakhov, member of the General Council, Chairman of the Kursk Regional Branch of the All-Russian Public Organisation Delovaya Rossiya, Alexey Martynov, President of the Biomedical Cell Products Manufacturers’ Association; and other guests of honour.
In his welcoming address to the attendees, ARPM General Director Viktor Dmitriev noted that “it has become a good tradition to discuss the year in review at Pharmtech & Ingredients. Today Pharmtech is not only an exhibition of achievements, but also the main exhibition of prospects.”
This year the exhibition was attended by 479 Russian and foreign companies from 33 countries, including more than 100 first-time exhibitors. The number of exhibitors grew by 7%. The total exposition area increased to 19,675 sq. meters, exceeding last year’s area by 6%. The manufacturers and suppliers from Germany, Switzerland, India and China were grouped within national pavilions. The number of Chinese companies, which offered raw materials and ingredients for pharmaceutical production to the Russian market, doubled.
During the Pharmtech & Ingredients exhibition, at which Swiss manufacturers have long been part of the national exposition, President of the Swiss Confederation Ueli Maurer arrived in Russia on an official visit. The negotiation of Mr. Maurer with Russian President V.V. Putin and Russian Prime Minister D.A. Medvedev focused on the issues of Russian-Swiss cooperation in trade, economic, scientific, technical, investment, cultural and humanitarian areas, including how to make it easier for small and medium Swiss businesses to enter the Russian market. The report on President Ueli Maurer’s visit and his interview were broadcast on the state-run television channel SRF. The report also covered the involvement of Swiss companies in the Pharmtech exhibition, and featured the exhibitors’ interviews. The Swiss national pavilion includes 15 companies, with their number increasing every year. This is clearly indicative of the trend towards the development and extension of cooperation, outlined by the presidents of Russia and Switzerland.
Over 4 days, the exhibition was visited by 8,231 people from 50 countries and 62 regions of Russia.
The companies traditionally displayed their innovative technologies and solutions intended to optimise production processes.
The exhibition’s business programme customarily included issues provoking heated discussions among pharma professionals. This year, such an issue has been the industry’s readiness to introduce drug labelling. The discussion featured representatives of all the pharmaceutical industry’s sectors likely to be affected by the project: Elena Kudryavtseva, Deputy Head of the Department for State Quality Control of Medical Products, Federal Service for Surveillance in Healthcare (Roszdravnadzor); Sergey Kholkin, Pharma Area Manager, operator company, Centre for Development of Advanced Technologies; and Margarita Mustafina, Project Manager of Teva LLC; Evgeny Nifantyev, Chairman of the Coordination Council, Russian Association of Pharmacy Chains Anatoly Tentser, Development Director of JSC SPC Katren; Mikhail Ignatov, Head of the Pharmacy Office, Moscow Department of Health; Vladimir Shipkov, Executive Director of the Association of International Pharmaceutical Manufacturers; Vadim Kukava, Executive Director of the Innovative Pharma Association of Pharmaceutical Companies; and German Inozemtsev, General Director of PharmaSpace Drug Ecosystem company. The round table was moderated by Victor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers (ARPM).
While it was a really hot discussion, many attendees agreed that the system had been built and technical solutions implemented, but some issues remained yet to be addressed and the industry’s readiness was incomplete. The round table panellists called on the gathered professionals to step up their efforts in disseminating information about the project, pay attention to its negative aspects requiring intervention, and speak out more openly about problems.
The following events were also held as part of the business programme: the round table “Export potential. New growth points” organised in partnership with the GMP News magazine, the discussion session “An effective look at the technical support of drug production”, and the round table “API production. The economic aspect”.
FPT LLC was a partner to the discussion session “An effective look at the technical support of drug production”. The participants touched upon the problem of efficiency at different stages of a pharmaceutical enterprise’s life cycle and gave special attention to the innovative solutions that improve efficiency at different stages.
The subjects of the round table “Export potential. New growth points” prompted heated debates. The panellists discussed state support measures and targets for pharmaceutical exports, growth prospects for the Eurasian Economic Union’s pharmaceutical market and its integration into the international trade system, operating procedures and creating entry points to overseas markets as exemplified by Russian and foreign companies.
The panellists of the round table “API production. The economic aspect” — heads of domestic companies — discussed how to furnish the Russian pharmaceutical industry with high-quality cost effective feedstock and domestically-made materials.
On 20 and 21 November, the 14th Pharmtechprom International Forum was held, with 4 sessions featuring Russian and international experts conducted as part of its programme.
A total of 1,128 people attended the business programme events.
In addition, the leading Russian and foreign pharmaceutical companies sponsor PharmtechTutor, an annual educational project implemented as part of the exhibition and intended for students from industry-specific educational institutions. This year was no exception: students from Yaroslavl State Medical University, Ivanovo State University of Chemistry and Technology, Pavlov State Medical University in Ryazan and some other industry-specific universities consolidated the existing and gained new expertise in the pharmaceutical industry area. All in all, 68 students from 11 universities who worked at the booths of 44 companies were involved in the PharmtechTutor programme this year.
The 22nd International Exhibition of Equipment, Raw Materials and Technologies for Pharmaceutical Production “Pharmtech & Ingredients” will be held at the Crocus Expo IEC on 10–13 November 2020.